Linoleic Acid-Based Transferosomes for Topical Ocular Delivery of Cyclosporine A

• Published in: Pharmaceutics 2022-08, Vol.14 (8), p.1695
• Main Authors: Uwaezuoke, Onyinye, Du Toit, Lisa C, Kumar, Pradeep, Ally, Naseer, Choonara, Yahya E
• Format: Article
• Language: English
• Subjects: Analysis; Biocompatibility; Cornea; Cyclosporine; cyclosporine A; Drug delivery systems; Drugs; Evaluation; Eye diseases; Fatty acids; Identification and classification; linoleic acid; Linoleic acids; Lipids; Liposomes; Methods; Molecular weight; nanoparticle drug-delivery systems; Permeability; Properties; Surfactants; Thin films; topical ocular drug delivery; transferosomes; Vehicles
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics14081695

Delivering high-molecular-weight hydrophobic peptides, such as cyclosporine A, across the corneal epithelium remains a challenge that is complicated by other physio-anatomical ocular structures that limit the ocular bioavailability of such peptides. Transferosomes have previously been used to improve transdermal permeability, and have the potential for improving the ocular corneal permeability of applicable drugs. In this study, transferosomes for the potential ocular delivery of cyclosporine A were investigated. Linoleic acid was evaluated for its effect on the stability of the transferosomes and was substituted for a portion of the cholesterol in the vesicles. Additionally, Span® 80 and Tween® 80 were evaluated for their effect on transferosome flexibility and toxicity to ocular cells as edge activators. Attenuated Total Reflectance–Fourier Transform Infrared spectroscopy (ATF-FTIR), differential scanning calorimetry (DSC), and dynamic light scattering (DLS) were used to evaluate the physicochemical parameters of the blank and the cyclosporine A-loaded transferosomes. Cyclosporine A release and corneal permeability were studied in vitro and in a New Zealand albino rabbit corneal model, respectively. The linoleic acid contributed to improved stability and the nano-size of the transferosomes. The Tween®-based formulation was preferred on the basis of a more favorable toxicity profile, as the difference in their corneal permeability was not significant. There was an initial burst release of cyclosporine A in the first 24 h that plateaued over one week. The Tween®-based formulation had a flux of 0.78 µg/cm2/h. The prepared transferosomes demonstrated biocompatibility in the ocular cell line, adequately encapsulated cyclosporine A, ensured the corneal permeability of the enclosed drug, and were stable over the period of investigation of 4 months at −20 °C.